[Form 4] Hillenbrand, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Bhavik N. Soni, Senior Vice President & Chief Information Officer of Hillenbrand, Inc. (HI), filed a Form 4 reporting several equity changes dated 09/30/2025 and signed 10/02/2025. The filing shows a disposition of 13,392 shares of Hillenbrand common stock and multiple acquisitions of Restricted Stock Units (RSUs) granted under prior award dates. The RSU entries record 5, 14, 25, 4, and 34 RSUs added to Mr. Soni's holdings, each settled in common stock and carrying dividend-equivalent rights.

The RSUs vest on specified schedules (one-third annual tranches for most awards) with one Matching RSU tied to the Executive Share Match framework vesting on March 31, 2028. After these transactions the filing reports updated beneficial ownership totals per award (for example 4,235 shares following the Matching RSU entry). The Form 4 discloses only the transactions and vesting schedules; no prices were paid for the RSUs and no additional commentary is included.

Positive

• Received multiple RSU grants (5, 14, 25, 4, and 34 units) that preserve future equity alignment
• RSUs include dividend-equivalent rights, maintaining economic equivalence to shares until settlement
• Vesting schedules extend to 2028, supporting multi-year retention incentives

Negative

• Disposition of 13,392 shares reported on 09/30/2025, reducing the officer's direct holdings
• Form 4 does not disclose sale price or reason for the 13,392-share disposition

Insights

Corporate Governance Analyst

Insider sold shares while receiving multiple RSU grants; vesting spans through 2028.

The Form 4 documents a sale of 13,392 shares on 09/30/2025, which reduces direct shareholdings reported by the officer. The filing also records acquisitions of RSUs granted on prior award dates that vest in annual tranches, preserving future equity exposure without immediate share delivery.

The Matching RSU under the Executive Share Match framework vests on March 31, 2028, indicating a multi-year retention mechanism. These entries are administrative disclosures of compensation-related awards and a single open-market or other disposition; the filing contains no price or intent statements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Soni Bhavik N.

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP & Chief Info. Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								13,392	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 12/7/2022)	(1)	09/30/2025		A(2)		5		(3)	(3)	Common Stock	5	$0	692	D
Restricted Stock Units (Deferred Stock Award 12/7/2023)	(1)	09/30/2025		A(2)		14		(4)	(4)	Common Stock	14	$0	1,779	D
Restricted Stock Units (Deferred Stock Award 12/5/2024)	(1)	09/30/2025		A(2)		25		(5)	(5)	Common Stock	25	$0	3,080	D
Restricted Stock Units (Deferred Stock Award 12/31/2024)	(1)	09/30/2025		A(2)		4		(6)	(6)	Common Stock	4	$0	552	D
Restricted Stock Units (Matching RSU Framework 03/31/2025)	(1)	09/30/2025		A(2)		34		(7)	(7)	Common Stock	34	$0	4,235	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025.

4. Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

5. Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

6. Restricted Stock Units scheduled to vest one-third on 12/31/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

7. Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-Fact for Bhavik N. Soni	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hillenbrand (HI) insider Bhavik Soni report on the Form 4?

The filing reports a disposition of 13,392 shares on 09/30/2025 and the acquisition of RSUs totaling 82 units across multiple prior award dates, with vesting schedules and dividend-equivalent rights.

When do the reported RSUs vest for Bhavik Soni?

Most RSUs vest in annual one-third tranches over three years per each award; the Matching RSU vests on March 31, 2028.

Did the Form 4 disclose any prices paid for the RSUs or the sold shares?

No. The RSUs are recorded with a $0 price (reflecting awards) and the filing does not state the sale price for the 13,392 shares.

Do the RSUs provide dividend rights?

Yes. The filing states RSUs are entitled to dividend equivalent rights which accrue on dividend record dates.

Who signed the Form 4 for Bhavik Soni?

The Form 4 is signed by Allison A. Westfall, Attorney-in-Fact for Bhavik N. Soni on 10/02/2025.